Radio-immunotherapy (RIT)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Radio-immunotherapy (RIT), covering 2014-06-25 to 2014-06-25. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Radio-immunotherapy (RIT) for Patients With Relapse or Refractory Acute Lymphoblastic Leukaemia (ALL) B CD22+ [Phase 1, Phase 2]